Long-term Efficacy and Safety of Gabapentin Enacarbil in Japanese Restless Legs Syndrome Patients

Phase 3 Completed 182 enrolled Astellas Pharma Inc

NaSingle-groupOpen-labelTreatment

Summary

The objective of this study is to evaluate the efficacy and safety of ASP8825 (gabapentin enacarbil) for long-term treatment of restless legs syndrome patients.

Timeline

Start: 2007-12
Primary completion: 2009-04
Completion: 2009-04

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	gabapentin enacarbil	Small molecule	—	Oral

Long-term Efficacy and Safety of Gabapentin Enacarbil in Japanese Restless Legs Syndrome Patients

Summary

Timeline

Drugs

Indications